---
title: "MASS: 23% Q2 revenue growth, 57% adjusted gross margin, and strong cash position drive outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295527188.md"
description: "Q2 2026 saw 23% revenue growth and a 57% adjusted gross margin, with a strong cash position and no debt. Strategic focus on handheld chemical analysis and recurring revenue, bolstered by the NIRLab acquisition, positions the company for continued growth.Original document: 908 Devices Inc. [MASS] Slides Release — Aug. 11 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-11T11:10:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295527188.md)
  - [en](https://longbridge.com/en/news/295527188.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295527188.md)
generator: "portal-rs"
---

# MASS: 23% Q2 revenue growth, 57% adjusted gross margin, and strong cash position drive outlook

Q2 2026 saw 23% revenue growth and a 57% adjusted gross margin, with a strong cash position and no debt. Strategic focus on handheld chemical analysis and recurring revenue, bolstered by the NIRLab acquisition, positions the company for continued growth.

Original document: 908 Devices Inc. \[MASS\] Slides Release — Aug. 11 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [MASS.US](https://longbridge.com/en/quote/MASS.US.md)

## Related News & Research

- [908 Devices CEO Kevin J. Knopp disposes of USD 283,477.32 in common shares](https://longbridge.com/en/news/296148424.md)
- [908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market](https://longbridge.com/en/news/295993916.md)
- [Memory: Everyone Puked The Lows. Now They're Chasing The Highs](https://longbridge.com/en/news/296139862.md)
- [GRVY: 2Q 2026 saw stable revenue, strong global growth, and a first-ever KRW 30bn interim dividend](https://longbridge.com/en/news/296137591.md)
- [14:30 ETMavrix defiende la importancia de la evidencia humana confiable en la era de la IA en el evento de Quirk](https://longbridge.com/en/news/296136546.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**